An innovative biotechnology company focused on the needs of patients with ophthalmic diseases.
Mannin Research Inc.
About Us
An Innovative
Biotechnology Company
Mannin seeks to develop and commercialize innovative new drugs to address the needs of patients with a focus on ophthalmic diseases. Mannin has developed novel therapeutics that target the Ang-Tie2 mechanism of action.
Mannin’s first indication is glaucoma, treating patients with novel, first-in-class drugs.